These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27085448)

  • 21. High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention.
    Liang J; Wang Z; Shi D; Liu Y; Zhao Y; Han H; Li Y; Liu W; Zhang L; Yang L; Zhou Y
    Angiology; 2015 Apr; 66(4):319-25. PubMed ID: 24913197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal course of vessel healing and neoatherosclerosis after DES implantation.
    Kozuki A; Shinke T; Otake H; Shite J; Nakagawa M; Nagoshi R; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hirata KI
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1121-1123. PubMed ID: 24135328
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.
    Xu K; Liu X; Li Y; Wang Y; Zang H; Guo L; Wang Y; Zhao W; Wang X; Han Y
    Cardiovasc Ther; 2016 Oct; 34(5):337-42. PubMed ID: 27328023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Jia H; Hu S; Liu H; Zhu Y; Zhe CY; Li L; Mustafina I; Hou J; Zhang S; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):582-591. PubMed ID: 28318139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
    Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy.
    Pesarini G; Dandale R; Rigamonti A; Pighi M; Zivelonghi C; Mugnolo A; Ferrero V; Vassanelli C; Ribichini F
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1056-65. PubMed ID: 23592553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.
    Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW
    EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical coherence tomography visualization of stent deformation with subsequent thrombus adhesion at very early phase after everolimus-eluting stent implantation: a case report.
    Yamamura S; Fujisue K; Tsujita K; Sakamoto K; Miyazaki Y; Kaikita K; Hokimoto S; Ogawa H
    BMC Cardiovasc Disord; 2016 May; 16():116. PubMed ID: 27245071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
    Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very late stent thrombosis in everolimus-eluting stent with predisposing mechanical factors: Differential features.
    Jaguszewski MJ; Cortes C; Daucher H; Schincariol M; Halejcio M; Besuch P; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(4):345-349. PubMed ID: 28831778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombus-Related Coronary High-Intensity Signal on T1-Weighted Magnetic Resonance Imaging Is a Potential Predictor of Adverse Cardiovascular Events After Stent Implantation.
    Matsumoto K; Ehara S; Hasegawa T; Nishimura S; Shimada K
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1364-1366. PubMed ID: 29454765
    [No Abstract]   [Full Text] [Related]  

  • 35. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
    Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Kreutz RP; Schmeisser G; Maatman B; Schaffter A; Sinha A; von der Lohe E; Breall JA
    Thromb Haemost; 2017 Jan; 117(2):426-428. PubMed ID: 27808346
    [No Abstract]   [Full Text] [Related]  

  • 38. Very Late Stent Thrombosis: Is There Any Limit, When to Stop Antiplatelet Therapy?
    Rahman MN; Gul I; Nabi A
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):260. PubMed ID: 28492160
    [No Abstract]   [Full Text] [Related]  

  • 39. Foreword.
    Curr Probl Cardiol; 2017 Dec; 42(12):402. PubMed ID: 29032851
    [No Abstract]   [Full Text] [Related]  

  • 40. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.